| Description |
1 online resource (343 p.) |
| Contents |
Cover -- Half Title -- Title Page -- Copyright Page -- Table of Contents -- List of Figures -- List of Tables -- Foreword -- Acknowledgements -- Editors -- Contributors -- Section I Green Synthesis of Nanoparticles from Natural Plant Parts -- General Overview -- The History of Nanotechnology -- Green Synthesis of Nanoparticles: Concepts and Scientific Context -- Application of Green Synthesized Nanoparticles in Human Health -- Antimicrobial Mechanism of Action -- Anticancer Mechanism of Action -- Non-Communicable Diseases -- Communicable Diseases -- Nanomedicine Innovations: New Trend |
|
Commercialization Aspects -- References -- Section II Nanotechnology for Treatment of Non-Communicable Diseases -- Chapter 1 Cancer Nanotheranostics: Next-Generation Early Detection and Treatment Prioritization for Cancers Using Phytonanotechnology -- 1.1 Introduction -- 1.2 Phytonanotechnology: Green Synthesis of Metallic Nanoparticles -- 1.3 Phytonanotechnology: Anticancer Activity -- 1.4 Phytonanotechnology: Mechanism of Action for Cancer Treatment -- 1.5 Cancer Nanotheranostics of Phytonanotechnology -- 1.6 Cancer Nanotheranostics of Phytonanotechnology: Opportunities |
|
1.7 Conclusion and Future Prospects -- References -- Chapter 2 Green Synthesis of Nanoparticles Using Plant Extracts: A Promising Antidiabetic Agent -- 2.1 Introduction -- 2.2 Nanotechnology and Diabetes Management -- 2.3 Plant Material and New Perspective of Nanoparticles as an Antidiabetic Agent -- 2.3.1 Some Antidiabetic Plant Extracts and Their Bioactive Compounds -- 2.3.2 Green Synthesis of Nanoparticles as Potential Antidiabetic Agents -- 2.4 Conclusion -- References -- Chapter 3 Green Nanoparticles: An Alternative Therapy for Oral Candidiasis -- 3.1 Oral Candidiasis -- 3.2 Management |
|
3.3 Nanotechnology -- 3.4 Green Nanotechnology -- 3.5 Green Synthesis -- 3.5.1 Sources of Green Nanoparticles -- 3.5.2 Process of Extraction from Plants -- 3.6 Green Nanoparticles -- 3.7 Metallic NPs against Candida -- 3.8 Zinc Oxide NPs and Candida -- 3.9 Conclusion -- References -- Section III Nanotechnology for Treatment of Communicable Diseases -- Chapter 4 Nanotechnology and Nanomedicine to Combat Ebola Virus Disease -- 4.1 Introduction -- 4.2 Ebola Virus Pathogenesis: Antiviral, Vaccine and Diagnostic Device Opportunities -- 4.3 Nanotechnology Platforms |
|
4.4 Nanotechnology Platforms for Treatment of Ebola Virus Infection -- 4.4.1 Lipid-Based Nanoparticles -- 4.4.2 Polymer-Based Nanoparticles -- 4.4.3 Inorganic Nanoparticles -- 4.5 Nanotechnology-Based Vaccines for Prevention of Ebola Virus Infection -- 4.6 Nanotechnology-Based Approach for Ebola Virus Diagnosis -- 4.7 Nanotechnology in Disinfection and Textile Applications: Future Prospects -- 4.8 Conclusion -- References -- Chapter 5 Application of Next-Generation Plant-Derived Nanobiofabricated Drugs for the Management of Tuberculosis -- 5.1 Introduction -- 5.2 History of Mtb |
| Notes |
Description based upon print version of record |
|
5.3 Transmission and Pathogenesis of Mtb |
| Form |
Electronic book
|
| Author |
Nyanganyura, Daniel
|
|
Mufamadi, Maluta Steven
|
|
Mulaudzi, Rofhiwa Bridget
|
| ISBN |
9781000351194 |
|
100035119X |
|
